Involvement of calmodulin in neuronal cell death

Brain Research

Volumn 1083, Issue 1, 2006, Pages 189-195

  Shirasaki, Yasufumi ^a   Kanazawa, Yoshito ^a   Morishima, Yoshiyuki ^a   Makino, Mitsuhiro ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

Ca2+ overload; Calmodulin; Excitotoxicity; Neuronal cell death

Indexed keywords

CALCIUM BINDING PROTEIN; CALMODULIN; GLUTAMIC ACID; MUTANT PROTEIN; POTASSIUM CHLORIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BRAIN CELL; BRAIN INJURY; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EXCITOTOXICITY; FUNCTIONAL PROTEOMICS; GENETIC TRANSFECTION; MEMBRANE DEPOLARIZATION; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; BRAIN; BRAIN ISCHEMIA; CALCIUM; CALCIUM SIGNALING; CALMODULIN; CELL DEATH; CELLS, CULTURED; CEREBRAL INFARCTION; CYTOPROTECTION; GLUTAMIC ACID; HUMANS; MEMBRANE POTENTIALS; MUTATION; NERVE DEGENERATION; NEUROTOXINS; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; TRANSFECTION;

EID: 33645957981     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.01.123     Document Type: Article

References (41)

1. Ahn E.Y., Lim S.T., Cook W.J., and McDonald J.M. Calmodulin binding to the Fas death domain. Regulation by Fas activation. J. Biol. Chem. 279 (2004) 5661-5666
2. Bartus R.T., Dean R.L., Cavanaugh K., Eveleth D., Carriero D.L., and Lynch G. Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J. Cereb. Blood Flow Metab. 15 (1995) 969-979
3. Buisson A., Margaill I., Callebert J., Plotkine M., and Boulu R.G. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia. J. Neurochem. 61 (1993) 690-696
4. Cartin L., Lounsbury K.M., and Nelson M.T. Coupling of Ca(2+) to CREB activation and gene expression in intact cerebral arteries from mouse: roles of ryanodine receptors and voltage-dependent Ca(2+) channels. Circ. Res. 86 (2000) 760-767
5. Cheng A., Wang S., Yang D., Xiao R., and Mattson M.P. Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons. J. Biol. Chem. 278 (2003) 7591-7599
6. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18 (1995) 58-60
7. 2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity. EMBO J. 16 (1997) 998-1008
8. Dawson T.M., Steiner J.P., Dawson V.L., Dinerman J.L., Uhl G.R., and Snyder S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 9808-9812
9. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., and Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13 (1993) 2651-2661
10. Dolmetsch R.E., Pajvani U., Fife K., Spotts J.M., and Greenberg M.E. Signaling to the nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase pathway. Science 294 (2001) 333-339
11. Frandsen A., and Schousboe A. Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons. J. Neurochem. 60 (1993) 1202-1211
12. Geiser J.R., van Tuinen D., Brockerhoff S.E., Neff M.M., and Davis T.N. Can calmodulin function without binding calcium?. Cell 65 (1991) 949-959
13. Hajimohammadreza I., Probert A.W., Coughenour L.L., Borosky S.A., Marcoux F.W., Boxer P.A., and Wang K.K. A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death. J. Neurosci. 15 (1995) 4093-4101
14. James P., Vorherr T., and Carafoli E. Calmodulin-binding domains: just two faced or multi-faceted?. Trends Biochem. Sci. 20 (1995) 38-42
15. Johnson G.V., Litersky J.M., and Jope R.S. Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study. J. Neurochem. 56 (1991) 1630-1638
16. Kimura Y., Corcoran E.E., Eto K., Gengyo-Ando K., Muramatsu M.A., Kobayashi R., Freedman J.H., Mitani S., Hagiwara M., Means A.R., and Tokumitsu H. A CaMK cascade activates CRE-mediated transcription in neurons of Caenorhabditis elegans. EMBO Rep. 3 (2002) 962-966
17. Kuroda S., Nakai A., Kristian T., and Siesjo B.K. The calmodulin antagonist trifluoperazine in transient focal brain ischemia in rats. Anti-ischemic effect and therapeutic window. Stroke 28 (1997) 2539-2544
18. Meldrum B., and Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11 (1990) 379-387
19. 2+ elevation induced by in vitro ischemia-like condition in hippocampal slices. Brain Res. 601 (1993) 103-110
20. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., Davis R.J., Shirasaki Y., and Greenberg M.E. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J. Neurosci. 21 (2001) 7551-7560
21. Nagafuji T., Matsui T., Koide T., and Asano T. Blockade of nitric oxide formation by N omega-nitro-l-arginine mitigates ischemic brain edema and subsequent cerebral infarction in rats. Neurosci. Lett. 147 (1992) 159-162
22. 2+ ATPase. J. Neurochem. 68 (1997) 1124-1134
23. Paschen W., Althausen S., and Doutheil J. Ischemia-induced changes in 2′-5′-oligoadenylate synthethase mRNA levels in rat brain: comparison with changes produced by perturbations of endoplasmic reticulum calcium homeostasis in neuronal cell cultures. Neurosci. Lett. 263 (1999) 109-112
24. Picone C.M., Grotta J.C., Earls R., Strong R., and Dedman J. Immunohistochemical determination of calcium-calmodulin binding predicts neuronal damage after global ischemia. J. Cereb. Blood Flow Metab. 9 (1989) 805-811
25. Roberts-Lewis J.M., Savage M.J., Marcy V.R., Pinsker L.R., and Siman R. Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 14 (1994) 3934-3944
26. Rotter B., Kroviarski Y., Nicolas G., Dhermy D., and Lecomte M.C. AlphaII-spectrin is an in vitro target for caspase-2, and its cleavage is regulated by calmodulin binding. Biochem. J. 378 (2004) 161-168
27. Saido T.C., Yokota M., Nagao S., Yamaura I., Tani E., Tsuchiya T., Suzuki K., and Kawashima S. Spatial resolution of fodrin proteolysis in postischemic brain. J. Biol. Chem. 268 (1993) 25239-25243
28. Sato T., Morishima Y., Sugimura M., Uchida T., and Shirasaki Y. DY-9760e, a novel calmodulin antagonist, reduces brain damage induced by transient focal cerebral ischemia. Eur. J. Pharmacol. 370 (1999) 117-123
29. Sato T., Morishima Y., and Shirasaki Y. 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemia. J. Pharmacol. Exp. Ther. 304 (2003) 1042-1047
30. Schmalzigaug R., Ye Q., and Berchtold M.W. Calmodulin protects cells from death under normal growth conditions and mitogenic starvation but plays a mediating role in cell death upon B-cell receptor stimulation. Immunology 103 (2001) 332-342
31. Schumacher A.M., Velentza A.V., and Watterson D.M. Death associated protein kinase as a potential therapeutic target. Expert Opin. Ther. Targets 6 (2002) 497-506
32. Seubert P., Baudry M., Dudek S., and Lynch G. Calmodulin stimulates the degradation of brain spectrin by calpain. Synapse 1 (1987) 20-24
33. Sharkey J., and Butcher S.P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature 371 (1994) 336-339
34. Siesjo B.K., and Bengtsson F. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis. J. Cereb. Blood Flow Metab. 9 (1989) 127-140
35. Sun X., Shin C., and Windebank A.J. Calmodulin in ischemic neurotoxicity of rat hippocampus in vitro. NeuroReport 8 (1997) 415-418
36. Takano H., Fukushi H., Morishima Y., and Shirasaki Y. Calmodulin and calmodulin-dependent kinase II mediate neuronal cell death induced by depolarization. Brain Res. 962 (2003) 41-47
37. Takano H., Sugimura M., Kanazawa Y., Uchida T., Morishima Y., and Shirasaki Y. Protective effect of DY-9760e, a calmodulin antagonist, against neuronal cell death. Biol. Pharm. Bull. 27 (2004) 1788-1791
38. 2+]i and glutamate neurotoxicity in vitro. J. Neurophysiol. 72 (1994) 1973-1992
39. Xia X.M., Fakler B., Rivard A., Wayman G., Johnson-Pais T., Keen J.E., Ishii T., Hirschberg B., Bond C.T., Lutsenko S., Maylie J., and Adelman J.P. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 395 (1998) 503-507
40. Yu W., Niwa T., Miura Y., Horio F., Teradaira S., Ribar T.J., Means A.R., Hasegawa Y., Senda T., and Niki I. Calmodulin overexpression causes Ca(2+)-dependent apoptosis of pancreatic beta cells, which can be prevented by inhibition of nitric oxide synthase. Lab. Invest. 82 (2002) 1229-1239
41. Zhou L.W., Moyer J.A., Muth E.A., Clark B., Palkovits M., and Weiss B. Regional distribution of calmodulin activity in rat brain. J. Neurochem. 44 (1985) 1657-1662